• Thu, May 5, 2022
Tiago Fauth Downgraded (BCAB) to Hold and Decreased Target to $5 on, May 5th, 2022
Tiago Fauth of Credit Suisse, Downgraded "BioAtla, Inc." (BCAB) to Hold and Decreased Target from $35 to $5 on, May 5th, 2022.
Tiago has made no other calls on BCAB in the last 4 months.
There is 1 other peer that has a rating on BCAB. Out of the 1 peers that are also analyzing BCAB, 0 agree with Tiago's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tiago
- Swayampakula Ramakanth of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $25 on, Monday, March 21st, 2022